The healthcare technology company has signed a new sales representative agreement to promote and sell its Xenon MRI platform in key US states, enhancing its commercial reach.
The medical imaging technology company has received FDA approval to expand the use of its XENOVIEW product to include children aged 6 and above, increasing the eligible patient population.
The medical imaging technology company announces that its Chief Scientific Officer has been awarded a prestigious honour by the American Thoracic Society for his pioneering work in Xenon MRI.
The medical imaging technology company's Xenon MRI platform will be featured prominently at the upcoming ATS 2025 conference, highlighting its growing recognition in the respiratory care field.
The medical imaging technology company announces an ongoing collaboration with Philips to bring advanced Xenon lung MRI to more children with chronic obstructive lung disease.
This medical device company reported revenue growth but continues to face losses and market headwinds. Despite improved cash position, ongoing challenges in profitability and market conditions raise concerns for investors.
The healthcare company has announced changes to its major shareholders, with several investment funds increasing their stakes.
The healthcare technology company announces the date for its full year results presentation.
The medical imaging technology company has expanded its Xenon MRI imaging platform to enable its use in pharma-sponsored research, securing a contract with a leading global pharmaceutical partner.
The medical imaging technology company reported a major revenue increase in FY24, exceeding guidance and highlighting strong commercial progress.